Alphatec Holdings, Inc. (ATEC) News
Filter ATEC News Items
ATEC News Results
|Loading, please wait...|
ATEC News Highlights
- For ATEC, its 30 day story count is now at 7.
- Over the past 8 days, the trend for ATEC's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
- KROS, BEAT and CORT are the most mentioned tickers in articles about ATEC.
Latest ATEC News From Around the Web
Below are the latest news stories about ALPHATEC HOLDINGS INC that investors may wish to consider to help them evaluate ATEC as an investment opportunity.
Alphatec Holdings ( NASDAQ:ATEC ) Third Quarter 2022 Results Key Financial Results Revenue: US$89.8m (up 43% from 3Q...
Analysts Are Bullish on These Healthcare Stocks: Keros Therapeutics (KROS), Corcept Therapeutics (CORT)
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Keros Therapeutics (KROS – Research Report), Corcept Therapeutics (CORT – Research Report) and Alphatec Holdings (ATEC – Research Report) with bullish sentiments. Keros Therapeutics (KROS) H.C. Wainwright analyst Andrew Fein reiterated a Buy rating on Keros Therapeutics today and set a price target of $100.00. The company's shares closed last Friday at $48.64. According to TipRanks.
Alphatec (ATEC) delivered earnings and revenue surprises of -9.38% and 3.18%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
CARLSBAD, Calif., November 03, 2022--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended September 30, 2022, and recent corporate highlights.
Today we will run through one way of estimating the intrinsic value of Alphatec Holdings, Inc. ( NASDAQ:ATEC ) by...
Globus Medical (GMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CARLSBAD, Calif., November 01, 2022--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will participate in the following investor events:
Alphatec (ATEC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Alphatec Holdings, Inc. ( NASDAQ:ATEC ), might not be a large cap stock, but it received a lot of attention from a...
Alphatec Holdings (ATEC - Research Report) received a Buy rating and a $12.00 price target from Jefferies analyst Matthew Taylor today. The company's shares closed yesterday at $9.72.Taylor covers the Healthcare sector, focusing on stocks such as Abbott Labs, Alphatec Holdings, and Baxter International. According to TipRanks, Taylor has an average return of 11.7% and a 62.13% success rate on recommended stocks. Alphatec Holdings has an analyst consensus of Strong Buy, with a price target consensus of $13.81, which is a 42.08% upside from current levels. In a report released yesterday, Morgan Stanley also maintained a Buy rating on the stock with a $15.00 price target.